A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

Anyone who rejects the benefits of science and the scientific method should toss away their smartphone, stop using the ...

Accessing primary literature, a format wherein the information comes straight from the researchers, can be daunting.

You're thinking of participating in a clinical trial – what now? Ask questions and weigh the risks before deciding if a clinical trial is right for you.

Find new ideas and classic advice on strategy, innovation and leadership, for global leaders from the world's best business and management experts.